These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28442372)

  • 1. Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2017 Aug; 117():244-255. PubMed ID: 28442372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into process understanding of solid lipid extrusion (SLE) of extruded lipid implants for sustained protein delivery.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2018 Sep; 130():11-21. PubMed ID: 29913270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of implant composition of twin-screw extruded lipid implants on the release behavior.
    Even MP; Bobbala S; Kooi KL; Hook S; Winter G; Engert J
    Int J Pharm; 2015 Sep; 493(1-2):102-10. PubMed ID: 26188320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
    Schulze S; Winter G
    J Control Release; 2009 Mar; 134(3):177-85. PubMed ID: 19121347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants.
    Sax G; Winter G
    J Control Release; 2012 Oct; 163(2):187-94. PubMed ID: 22964391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of stability and biophysical characterization of ranibizumab and aflibercept.
    Moreno MR; Tabitha TS; Nirmal J; Radhakrishnan K; Yee CH; Lim S; Venkatraman S; Agrawal R
    Eur J Pharm Biopharm; 2016 Nov; 108():156-167. PubMed ID: 27615995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable formulations for an intravitreal sustained-release application of a novel single-chain VEGF antibody fragment.
    Asmus LR; Grimshaw JP; Richle P; Eicher B; Urech DM; Gurny R; Möller M
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):250-60. PubMed ID: 25779352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating release of ranibizumab and aflibercept from thiolated chitosan-based hydrogels for potential treatment of ocular neovascularization.
    Moreno M; Pow PY; Tabitha TST; Nirmal S; Larsson A; Radhakrishnan K; Nirmal J; Quah ST; Geifman Shochat S; Agrawal R; Venkatraman S
    Expert Opin Drug Deliv; 2017 Aug; 14(8):913-925. PubMed ID: 28643528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Sustainable Release System for a Ranibizumab Biosimilar Using Poly(lactic-co-glycolic acid) Biodegradable Polymer-Based Microparticles as a Platform.
    Tanetsugu Y; Tagami T; Terukina T; Ogawa T; Ohta M; Ozeki T
    Biol Pharm Bull; 2017; 40(2):145-150. PubMed ID: 28154252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP; Young K; Winter G; Hook S; Engert J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous release of Rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage forms.
    Mohl S; Winter G
    Pharm Dev Technol; 2006 Feb; 11(1):103-10. PubMed ID: 16544914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies.
    Zhang L; Si T; Fischer AJ; Letson A; Yuan S; Roberts CJ; Xu RX
    PLoS One; 2015; 10(8):e0135608. PubMed ID: 26273831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-coated mannitol core microparticles for sustained release of protein.
    Wang B; Friess W
    Eur J Pharm Biopharm; 2018 Jul; 128():91-97. PubMed ID: 29684533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability.
    Yan X; He H; Meng J; Zhang C; Hong M; Tang X
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1221-9. PubMed ID: 22713120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity.
    Dadgar Pakdel F; Mirshahi A; Zahedi P; Mohammad K; Hemmati F; Dadgar Pakdel J; Nicknam MH; Abedin Dorkoosh F
    Adv Pharm Bull; 2021 Sep; 11(4):632-642. PubMed ID: 34888210
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards controlled release of BDNF--manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain.
    Koennings S; Sapin A; Blunk T; Menei P; Goepferich A
    J Control Release; 2007 Jun; 119(2):163-72. PubMed ID: 17428570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twin-screw extruded lipid implants containing TRP2 peptide for tumour therapy.
    Even MP; Bobbala S; Gibson B; Hook S; Winter G; Engert J
    Eur J Pharm Biopharm; 2017 May; 114():79-87. PubMed ID: 28104440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device.
    Lance KD; Bernards DA; Ciaccio NA; Good SD; Mendes TS; Kudisch M; Chan E; Ishikiriyama M; Bhisitkul RB; Desai TA
    Drug Deliv Transl Res; 2016 Dec; 6(6):771-780. PubMed ID: 27178165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid extrusion of sustained release dosage forms.
    Reitz C; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
    Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
    Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.